Section one: Contracting authority
one.1) Name and addresses
Procurement and Logistics Service
Supplies Centre, Gransha Hospital
Londonderry
BT47 6YZ
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
https://etendersni.gov.uk/epps
Buyer's address
https://etendersni.gov.uk/epps
one.1) Name and addresses
Belfast Health and Social Care Trust
A Floor, Belfast City Hospital, Lisburn Road
Belfast
BT9 7AB
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
https://etendersni.gov.uk/epps
Buyer's address
https://etendersni.gov.uk/epps
one.1) Name and addresses
Western Health and Social Care Trust
Altnagelvin Area Hospital, Glenshane Road
Londonderry
BT47 6SB
Country
United Kingdom
NUTS code
UK - UNITED KINGDOM
Internet address(es)
Main address
https://etendersni.gov.uk/epps
Buyer's address
https://etendersni.gov.uk/epps
one.2) Information about joint procurement
The contract involves joint procurement
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://etendersni.gov.uk/epps
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://etendersni.gov.uk/epps
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.1.2) Main CPV code
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.1.3) Type of contract
Supplies
two.1.4) Short description
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.1.5) Estimated total value
Value excluding VAT: £11,607,952
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for maximum number of lots
32
two.2) Description
two.2.1) Title
Lot 1: Ioflupane I-123
Lot No
1
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £2,336,340
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 2: MIBG I-123 (metaiodobenzylguanidine)
Lot No
2
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £156,576
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 3: Sodium Iodide I-123
Lot No
3
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £89,803
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 4: Sodium Iodide Therapy Capsule I-131
Lot No
4
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £254,872
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 5: Sodium Iodide Liquid I-131
Lot No
5
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £1,252
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 6: Therapeutic MIBG I-131 (metaiodobenzylguanidine)
Lot No
6
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £99,613
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 7: Gallium Citrate Ga-67
Lot No
7
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £1,788
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 8: Generator Krypton Gas Kr-81
Lot No
8
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £262,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 9: Generator Technetium Mo-99/Tc-99m
Lot No
9
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £1,283,128
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 10: Samarium Sm-135
Lot No
10
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £14,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 11: Selenium Homocholic Acid Taurine/Tauroselcholic Acid Se-75
Lot No
11
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £448,380
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 12: Radium Dichloride Ra-223
Lot No
12
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £786,480
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 13: Indium DTPA In-111 (Diethylenetriamine Pentaacetate)
Lot No
13
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £1,480
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 14: OCTREOSCAN 122MBQ IN111 (OCTREOTIDE)
Lot No
14
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £260,640
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 15: DMSA (Dimercaptosuccinic Acid)
Lot No
15
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £29,872
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 16: DTPA (Diethylenetriamine Pentaacetate)
Lot No
16
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £12,132
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 17: Exametazime
Lot No
17
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £82,200
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 18: HDP (Hydroxymethylene Diphosphonate)
Lot No
18
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £51,040
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 19: Human Albumin Nanocolloid
Lot No
19
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £91,900
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 20: MAA (Macro Aggregated Albumin)
Lot No
20
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £49,432
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 21: Mertiatide
Lot No
21
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £90,640
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 22: Mebrofenin
Lot No
22
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £6,120
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 23: MIBI (Sestamibi - Methoxyisobutylisonitrile)
Lot No
23
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £147,062
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 24: Sodium Pyrophosphate
Lot No
24
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £1,672
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 25: Tetrofosmin
Lot No
25
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £139,280
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 26: Tin Colloid
Lot No
26
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £460
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
LOT 27 – Tektrotyd
Lot No
27
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £287,250
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
LOT 28 - Diphosphono-Propanedicarbosylic Acid (DPD)
Lot No
28
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £2,480
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
LOT 29 - Sirspheres
Lot No
29
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £926,540
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
LOT 30 - Lutathera
Lot No
30
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £4,450,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
Lot 31- Yttrium Silicate Y-90
Lot No
31
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £19,437
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
two.2) Description
two.2.1) Title
LOT 32 - Sterile Nitrogen Vials
Lot No
32
two.2.2) Additional CPV code(s)
- 33000000 - Medical equipments, pharmaceuticals and personal care products
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials
two.2.5) Award criteria
Price
two.2.6) Estimated value
Value excluding VAT: £55,584
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: Yes
Description of options
It is anticipated that this Framework Agreement will commence on 1st June 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
Envisaged maximum number of participants to the framework agreement: 3
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
8 February 2021
Local time
3:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until: 8 June 2021
four.2.7) Conditions for opening of tenders
Date
8 February 2021
Local time
3:30pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Business Services Organisation, PaLS
77 Boucher Crescent
Belfast
BT12 6HU
Country
United Kingdom